Glenmark Pharmaceuticals has received final approval from the US health regulator for a generic version of Temovate Topical Solution used to treat certain scalp and skin conditions.
Glenmark Pharmaceuticals USA has been granted final approval by the US Food and Drug Administration for Clobetasol Propionate Topical Solution USP, 0.05%, the company said in a BSE filing.
The approved product is the generic version of Temovate Topical Solution.
Glenmark Pharmaceuticals USA has been granted final approval by the US Food and Drug Administration for Clobetasol Propionate Topical Solution USP, 0.05%, the company said in a BSE filing.
The approved product is the generic version of Temovate Topical Solution.
For more information Call us ✆ +91 9111-179961 or Visit Dollar Advisory
No comments:
Post a Comment